furosemide nebulization efficacy in acute reactive airway disease
Not Applicable
- Conditions
- Acute Reactive Airway Disease.chronic obstructive pulmonary disease
- Registration Number
- IRCT201201272782N2
- Lead Sponsor
- Ahvaz Jundishapur University of Medical Siences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Patients 18-55 years old with clinical manifestation of acute recative airway disease presenting in emergency department
Exclsion criteria:Onset of symptoms more than 10 hours;smoking more than 10 pack/year; associated acute medical problem; pregnancy; nebulization with B-agonist during last hours.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acute Reactive Airway Didease Severity. Timepoint: Before and 45 minutes after intervention. Method of measurement: American Thoracic Society definition.;Peak Expiratory Flow Rate. Timepoint: Before and 15,30 nd 45 minutes after intervention. Method of measurement: Peak flow meter.
- Secondary Outcome Measures
Name Time Method